A detailed history of Raymond James & Associates transactions in Tekla Healthcare Investors stock. As of the latest transaction made, Raymond James & Associates holds 355,205 shares of HQH stock, worth $5.79 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares
355,205
Previous 197,587 79.77%
Holding current value
$5.79 Million
Previous $3.45 Million 91.74%
% of portfolio
0.0%
Previous 0.0%

Shares

30 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 18, 2024

BUY
$17.4 - $19.67 $2.74 Million - $3.1 Million
157,618 Added 79.77%
355,205 $6.61 Million
Q2 2024

Jul 19, 2024

BUY
$15.78 - $17.58 $29,145 - $32,470
1,847 Added 0.94%
197,587 $3.45 Million
Q1 2024

Apr 22, 2024

BUY
$16.46 - $17.44 $479,199 - $507,730
29,113 Added 17.47%
195,740 $3.3 Million
Q4 2023

Jan 16, 2024

SELL
$14.32 - $16.57 $62,005 - $71,748
-4,330 Reduced 2.53%
166,627 $2.76 Million
Q3 2023

Oct 24, 2023

BUY
$15.52 - $17.49 $155,712 - $175,477
10,033 Added 6.23%
170,957 $2.66 Million
Q2 2023

Jul 25, 2023

BUY
$16.52 - $17.9 $255,465 - $276,805
15,464 Added 10.63%
160,924 $2.74 Million
Q1 2023

Apr 14, 2023

BUY
$16.86 - $19.02 $29,656 - $33,456
1,759 Added 1.22%
145,460 $2.57 Million
Q4 2022

Feb 08, 2023

BUY
$17.4 - $19.47 $142,210 - $159,128
8,173 Added 6.03%
143,701 $2.59 Million
Q3 2022

Oct 25, 2022

BUY
$17.08 - $20.71 $64,869 - $78,656
3,798 Added 2.88%
135,528 $2.34 Million
Q2 2022

Aug 12, 2022

SELL
$17.53 - $21.84 $1.45 Million - $1.81 Million
-82,880 Reduced 38.62%
131,730 $2.46 Million
Q1 2022

May 11, 2022

SELL
$18.93 - $24.02 $580,545 - $736,645
-30,668 Reduced 12.5%
214,610 $4.46 Million
Q4 2021

Feb 08, 2022

SELL
$22.75 - $26.5 $387,751 - $451,666
-17,044 Reduced 6.5%
245,278 $5.83 Million
Q3 2021

Nov 02, 2021

SELL
$25.11 - $27.93 $385,714 - $429,032
-15,361 Reduced 5.53%
262,322 $6.71 Million
Q2 2021

Aug 11, 2021

BUY
$23.09 - $25.91 $936,068 - $1.05 Million
40,540 Added 17.1%
277,683 $7.15 Million
Q1 2021

May 14, 2021

BUY
$22.8 - $25.84 $1.37 Million - $1.55 Million
60,155 Added 33.99%
237,143 $5.79 Million
Q4 2020

Feb 12, 2021

BUY
$19.72 - $23.83 $1.25 Million - $1.51 Million
63,408 Added 55.83%
176,988 $4.22 Million
Q3 2020

Nov 04, 2020

BUY
$19.71 - $22.33 $417,516 - $473,016
21,183 Added 22.93%
113,580 $2.34 Million
Q2 2020

Jul 28, 2020

SELL
$16.98 - $21.6 $1,324 - $1,684
-78 Reduced 0.08%
92,397 $1.97 Million
Q1 2020

Apr 21, 2020

SELL
$14.77 - $21.66 $1.11 Million - $1.62 Million
-74,943 Reduced 44.76%
92,475 $1.65 Million
Q4 2019

Feb 12, 2020

SELL
$17.86 - $21.36 $912,628 - $1.09 Million
-51,099 Reduced 23.38%
167,418 $3.5 Million
Q3 2019

Nov 07, 2019

SELL
$18.24 - $20.34 $608,632 - $678,705
-33,368 Reduced 13.25%
218,517 $4.01 Million
Q2 2019

Aug 06, 2019

SELL
$18.85 - $20.79 $1.27 Million - $1.41 Million
-67,619 Reduced 21.16%
251,885 $5.06 Million
Q1 2019

May 06, 2019

BUY
$18.39 - $21.16 $39,207 - $45,113
2,132 Added 0.67%
319,504 $6.56 Million
Q4 2018

Feb 11, 2019

SELL
$16.57 - $23.12 $1.2 Million - $1.67 Million
-72,290 Reduced 18.55%
317,372 $5.7 Million
Q3 2018

Nov 14, 2018

BUY
$21.53 - $23.25 $334,877 - $361,630
15,554 Added 4.16%
389,662 $9.02 Million
Q2 2018

Aug 14, 2018

BUY
$20.46 - $22.21 $641,523 - $696,394
31,355 Added 9.15%
374,108 $8.04 Million
Q1 2018

May 14, 2018

BUY
$21.28 - $24.62 $518,338 - $599,693
24,358 Added 7.65%
342,753 $7.38 Million
Q4 2017

Feb 14, 2018

BUY
$21.77 - $25.76 $2.12 Million - $2.51 Million
97,501 Added 44.14%
318,395 $7.18 Million
Q3 2017

Nov 13, 2017

BUY
$23.83 - $25.73 $370,175 - $399,689
15,534 Added 7.56%
220,894 $5.57 Million
Q2 2017

Aug 14, 2017

BUY
N/A
205,360
205,360 $5.16 Million

Others Institutions Holding HQH

About TEKLA HEALTHCARE INVESTORS


  • Ticker HQH
  • Exchange NYSE
  • Sector Financial Services
  • Industry Asset Management
  • Description
  • Tekla Healthcare Investors is a closed-ended equity mutual fund launched and managed by Tekla Capital Management LLC. The fund invests in public equity markets across the globe. It seeks to invest in stocks of companies operating in the healthcare sector, including the biotechnology, medical devices, and pharmaceuticals industries. The fund prim...
More about HQH
Track This Portfolio

Track Raymond James & Associates Portfolio

Follow Raymond James & Associates and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Raymond James & Associates, based on Form 13F filings with the SEC.

News

Stay updated on Raymond James & Associates with notifications on news.